[Duration of bronchial protective effect of salmeterol in asthma induced by hyperventilation with dry cold air]
- PMID: 1350365
[Duration of bronchial protective effect of salmeterol in asthma induced by hyperventilation with dry cold air]
Abstract
The duration of the blocking effect of salmeterol (50 micrograms), albuterol (200 micrograms) and placebo was compared in a double-blind study carried out in 12 adult asthmatic subjects who underwent hyperventilation tests with cold dry air on 4 study days. On the first day, the hyperventilation test was carried out at various time intervals with spontaneous functional recovery between each test. The response was assessed by interpolating the dose of cold dry air causing a 20% fall in FEV1 (PD20). On the three other days, the active or placebo medications were administered. Spirometry was assessed 15 minutes and 1 hour later. The hyperventilation test was then performed and repeated at various time intervals after administering the drug. The mean duration of the blocking effect was 0.25 hour for placebo, 3.5 hours for albuterol, and of 15.9 hours for salmeterol. Eight of the 12 subjects still showed some blocking effect eight hours after salmeterol by comparison with only one subject after albuterol. The authors conclude that salmeterol has a significantly longer effect than albuterol on bronchoconstriction induced by hyperventilation.
Similar articles
-
Salmeterol, a new inhaled beta 2-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction.J Allergy Clin Immunol. 1992 Feb;89(2):567-74. doi: 10.1016/0091-6749(92)90324-u. J Allergy Clin Immunol. 1992. PMID: 1346793 Clinical Trial.
-
Formoterol, a new inhaled beta-2 adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction.Am Rev Respir Dis. 1990 Nov;142(5):1147-52. doi: 10.1164/ajrccm/142.5.1147. Am Rev Respir Dis. 1990. PMID: 1978619 Clinical Trial.
-
Duration of action of inhaled terbutaline at two different doses and of albuterol in protecting against bronchoconstriction induced by hyperventilation of dry cold air in asthmatic subjects.Am Rev Respir Dis. 1989 Sep;140(3):817-21. doi: 10.1164/ajrccm/140.3.817. Am Rev Respir Dis. 1989. PMID: 2782749 Clinical Trial.
-
A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects.Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):626-9. doi: 10.1164/ajrccm/144.3_Pt_1.626. Am Rev Respir Dis. 1991. PMID: 1679981 Clinical Trial.
-
[Bronchodilator effect of salmeterol and inhibition of bronchial hyperreactivity].Rev Mal Respir. 1992;9 Suppl 1:R11-3. Rev Mal Respir. 1992. PMID: 1350363 Review. French.